Literature DB >> 16735810

Recent developments in the perioperative fluid management for the paediatric patient.

Olivier Paut1, Frédéric Lacroix.   

Abstract

PURPOSE OF REVIEW: Maintenance fluid therapy represents the volume of fluids and amount of electrolytes and glucose needed to replace anticipated physiological losses from breath, sweat and urine and to prevent hypoglycaemia. For 50 years, this therapy was based on Holliday and Segar's formula, which proposed to match children's water and electrolyte requirements on a weight-based calculation using hypotonic solutions. Recent publications highlight the risk of hyponatraemia in the postoperative period and the facilitating role of a hypotonic infusion, leading some people to recommend replacing hypotonic with isotonic solutions. RECENT
FINDINGS: The postoperative period is at risk for nonosmotic secretion of antidiuretic hormone, which reduces the ability of the kidneys to excrete free water. In the context of antidiuretic hormone release, the associated low urine output makes maintenance volume requirement decrease to 50% of the calculated hourly rate. While isotonic fluids are recommended during anaesthesia, controversies still exist on the nature of fluid for maintenance therapy in the postoperative period. The proof for a benefit of isotonic fluids in this context is weak; further investigations are needed to make a decision. Whatever the choice, an individualized maintenance infusion protocol for each patient is necessary.
SUMMARY: As free water excretion is altered for all children in the postoperative period, it is necessary to reduce the volume of maintenance fluid therapy to half the previously recommended volume. The choice of an isotonic solution should be more pertinent to that of a hypotonic solution, but evidence is lacking for a definitive answer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735810     DOI: 10.1097/01.aco.0000192818.68730.9d

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  9 in total

Review 1.  [Determinants of insensible fluid loss. Perspiration, protein shift and endothelial glycocalyx].

Authors:  M Jacob; D Chappell; K Hofmann-Kiefer; P Conzen; K Peter; M Rehm
Journal:  Anaesthesist       Date:  2007-08       Impact factor: 1.041

Review 2.  Impact of perioperative hyponatremia in children: A narrative review.

Authors:  Cheme Andersen; Arash Afshari
Journal:  World J Crit Care Med       Date:  2014-11-04

3.  Fluid balance in late preterm infants with prenatal gastrointestinal pathology -a report of two cases-.

Authors:  Byung Hoo Bahk; Hae Mi Lee
Journal:  Korean J Anesthesiol       Date:  2013-11-29

Review 4.  Anesthesia for children with mitochondrial disorders: a national survey and review.

Authors:  Muhammad B Rafique; Staci D Cameron; Qaiser Khan; Suur Biliciler; Salman Zubair
Journal:  J Anesth       Date:  2012-09-25       Impact factor: 2.078

5.  Iatrogenic hyponatremia in hospitalized children: Can it be avoided?

Authors:  Peter Skippen; Robert Adderley; Mary Bennett; Arthur Cogswell; Norbert Froese; Mike Seear; David Wensley
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

6.  Basics of fluid and blood transfusion therapy in paediatric surgical patients.

Authors:  Virendra K Arya
Journal:  Indian J Anaesth       Date:  2012-09

Review 7.  Perioperative fluid therapy and intraoperative blood loss in children.

Authors:  Neerja Bhardwaj
Journal:  Indian J Anaesth       Date:  2019-09

8.  Postoperative hyponatremia in neonates with esophageal atresia and tracheoesophageal fistula receiving restricted hypotonic fluids.

Authors:  Shivani Dogra; Muneer A Malik; Nitin J Peters; Ram Samujh
Journal:  Ann Pediatr Surg       Date:  2022-09-21

9.  Hypotonic fluid reduce serum sodium compared to isotonic fluids during anesthesia induction in pediatric patients undergoing maxillofacial surgery-type of infusion affects blood electrolytes and glucose: an observational study.

Authors:  Kentaro Ouchi; Kazuna Sugiyama
Journal:  BMC Pediatr       Date:  2016-07-27       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.